The global respiratory inhalers market size was valued at USD 33.5 billion in 2023, with Europe holding a significant market share. It is driven by the increasing number of respiratory disease cases in the region. The market is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032, and attain a value of USD 53.9 billion by 2032.